Improving Antiretroviral Management for HIV
Improving Antiretroviral Management for HIV
批准号:
8848023
负责人:
RICHARD H HAUBRICH
金额:
$19.31万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-03-15 至 2015-03-22
关键词:
AdherenceAfrican AmericanAnti-Retroviral AgentsAntiretroviral resistanceApplications GrantsBehaviorBehavioralCaliforniaCaregiversCensusesChlamydia trachomatisClinicalClinical ResearchCommunicable DiseasesCommunitiesDataDevelopmentDoseDrug resistanceEnsureEthnic OriginEventFacultyFailureFamily memberFundingGenderGoalsGrantHIVIncidenceIndividualIngestionInstitutional Review BoardsInternetInterventionInvestigationLaboratoriesMeasuresMentorsMethodologyMethodsMolecularNeisseria gonorrhoeaeOutcomePathogenesisPatientsPhylogenetic AnalysisPhysiciansPrevalencePrincipal InvestigatorProcessPublicationsRaceResearch Project GrantsResistanceRiskRisk FactorsRisk ReductionSamplingScienceScientistSiteSurveysSyphilisSystemTenofovirTimeTraining ProgramsWalkersWomanWorkWritingcareercohortdata sharingefavirenzemtricitabinegraduate studenthigh risk behaviorhigh risk sexual behaviorimprovedmedication compliancemeetingsmenmucosal sitenext generationnovelprotocol developmentsensorsexually activetransmission processtrend
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The goal of this K24 renewal application is to allow the applicant to continue to mentor trainees pursuing a career in clinical HIV investigation. This application would provide continued opportunities to utilize ongoing and planned clinical studies to mentor Infectious Disease fellows, junior faculty and graduate students in HIV related clinical research projects through the UCSD AVRC, the California Collaborative Treatment Group (CCTG) and the CFAR Network of Integrated Clinical Systems (CNICS) and to continue to expand the applicant's participation in the UCSD training programs for clinical research. The studies outlined in the aims provide opportunities for in-depth mentoring as well as investigation of timely and important scientific questions in HIV management and pathogenesis. For each of the aims and sub-aims, a mentee is the primary leader of the study: trainees have worked with the applicant to develop the studies from the inception and will participate in every aspect of protocol development, study execution, statistical analyses, results interpretation, presentation and publication of the results. All of the main studies are funded (mentees participated in the grant writing process) and for laboratory sub-aims, trainees have participated in recently submitted grant applications.
The goal of mentoring will be achieved through the conduct of 2 scientific aims which incorporate several clinical studies. SPECIFIC AIM 1: To analyze CNICS cohort data to evaluate trends in antiretroviral (ARV) exposure and resultant virologic and resistance outcomes including disparities in outcome among women and African Americans. Clinical Studies: CNICS 002, CNICS 019 plus new CNICS concept proposal in development. SPECIFIC AIM 2: To investigate technologic and behavioral methodologies which improve adherence to ARV and reduce high-risk behavior in order to potentially reduce transmission from HIV- infected subjects. Clinical studies: CCTG 592 and new CCTG studies in development.
The goal of this project is to allow the Principal Investigator to continue to mentor trainees pursuing a career in clinical HIV investigation. This application would provide continued opportunities to utilize ongoing and planned clinical studies to mentor Infectious Disease fellows, junior faculty and graduate students in HIV related clinical research projects through the UCSD AVRC, the California Collaborative Treatment Group (CCTG) and the CFAR Network of Integrated Clinical Systems (CNICS). Ultimately, the project would help to ensure that the next generation of scientists is available to meet the challenges of improving science and treatment of HIV infected patients.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1521/aeap.2013.25.6.495
发表时间:
2013-12
期刊:
AIDS education and prevention : official publication of the International Society for AIDS Education
影响因子:
--
作者:
[Tran BR, Thomas AG, Vaida F, Ditsela M, Phetogo R, Kelapile D, Chambers C, Haubrich R, Shaffer R]
通讯作者:
Shaffer R
DOI:
10.1001/virtualmentor.2014.16.11.stas1-1411
发表时间:
2014-11-01
期刊:
The virtual mentor : VM
影响因子:
--
作者:
[Blumenthal, Jill, Haubrich, Richard H]
通讯作者:
Haubrich, Richard H
A computer-based system to aid in the interpretation of plasma concentrations of antiretrovirals for therapeutic drug monitoring.
一种基于计算机的系统,有助于解释抗逆转录病毒药物的血浆浓度,以进行治疗药物监测。
DOI:
--
发表时间:
2007
期刊:
Antiviral therapy
影响因子:
1.2
作者:
[Goicoechea,Miguel, Vidal,Andrea, Capparelli,Edmund, Rigby,Andrew, Kemper,Carol, Diamond,Catherine, Witt,MalloryD, Haubrich,Richard, CaliforniaCollaborativeTreatmentGroup]
通讯作者:
CaliforniaCollaborativeTreatmentGroup
Screening for atherosclerotic vascular disease in HIV-infected children
-
批准号:8839837
-
项目类别:
-
资助金额:$34.45万
-
财政年份:2015
-
负责人:RICHARD H HAUBRICH
-
依托单位:
Assessing the Clinical Consequences of HIV Drug Resistance
-
批准号:7555003
-
项目类别:
-
资助金额:$19.31万
-
财政年份:2008
-
负责人:RICHARD H HAUBRICH
-
依托单位:
Assessing the Clinical Consequences of HIV Drug Resistance
-
批准号:7690947
-
项目类别:
-
资助金额:$23.18万
-
财政年份:2008
-
负责人:RICHARD H HAUBRICH
-
依托单位:
Clinical Investigation
-
批准号:7635789
-
项目类别:
-
资助金额:$22.42万
-
财政年份:2008
-
负责人:RICHARD H HAUBRICH
-
依托单位:
Clinical Investigation
-
批准号:7278950
-
项目类别:
-
资助金额:$23.3万
-
财政年份:2007
-
负责人:RICHARD H HAUBRICH
-
依托单位:
Improving Antiretroviral Management for HIV
-
批准号:7064358
-
项目类别:
-
资助金额:$15.48万
-
财政年份:2006
-
负责人:RICHARD H HAUBRICH
-
依托单位:
ACTG A5142 LOPINAVIR/RITONAVIR PLUS EFAVIRENZ FOR HIV-1 INFECTION
-
批准号:7374177
-
项目类别:
-
资助金额:$1.17万
-
财政年份:2006
-
负责人:RICHARD H HAUBRICH
-
依托单位:
Improving Antiretroviral Management for HIV
-
批准号:8140837
-
项目类别:
-
资助金额:$19.31万
-
财政年份:2006
-
负责人:RICHARD H HAUBRICH
-
依托单位:
Improving Antiretroviral Management for HIV
-
批准号:7578888
-
项目类别:
-
资助金额:$16.94万
-
财政年份:2006
-
负责人:RICHARD H HAUBRICH
-
依托单位:
Improving Antiretroviral Management for HIV
-
批准号:8423355
-
项目类别:
-
资助金额:$19.31万
-
财政年份:2006
-
负责人:RICHARD H HAUBRICH
-
依托单位:
Improving Antiretroviral Management for HIV
-
批准号:8623093
-
项目类别:
-
资助金额:$19.31万
-
财政年份:2006
-
负责人:RICHARD H HAUBRICH
-
依托单位:
Improving Antiretroviral Management for HIV
-
批准号:7380061
-
项目类别:
-
资助金额:$16.1万
-
财政年份:2006
-
负责人:RICHARD H HAUBRICH
-
依托单位:
Improving Antiretroviral Management for HIV
-
批准号:8225166
-
项目类别:
-
资助金额:$19.31万
-
财政年份:2006
-
负责人:RICHARD H HAUBRICH
-
依托单位:
ACTG A5142 LOPINAVIR/RITONAVIR PLUS EFAVIRENZ FOR HIV -1 INFECTION
-
批准号:7606527
-
项目类别:
-
资助金额:$0.33万
-
财政年份:2006
-
负责人:RICHARD H HAUBRICH
-
依托单位:
Improving Antiretroviral Management for HIV
-
批准号:7195818
-
项目类别:
-
资助金额:$15.97万
-
财政年份:2006
-
负责人:RICHARD H HAUBRICH
-
依托单位:
ACTG A5079 PHYSIOLOGIC TESTOSTERONE SUPPLEMENTATION IN HIV
-
批准号:7374162
-
项目类别:
-
资助金额:$0.39万
-
财政年份:2006
-
负责人:RICHARD H HAUBRICH
-
依托单位:
ACTG A5142 LOPINAVIR/RITONAVIR PLUS EFAVIRENZ FOR HIV-1 INFECTION
-
批准号:7045466
-
项目类别:
-
资助金额:$0.44万
-
财政年份:2003
-
负责人:RICHARD H HAUBRICH
-
依托单位:
ACTG A5079 PHYSIOLOGIC TESTOSTERONE SUPPLEMENTATION IN HIV
-
批准号:7205600
-
项目类别:
-
资助金额:$1.17万
-
财政年份:2003
-
负责人:RICHARD H HAUBRICH
-
依托单位:
ACTG A5142 LOPINAVIR/RITONAVIR PLUS EFAVIRENZ FOR HIV-1 INFECTION
-
批准号:7205632
-
项目类别:
-
资助金额:$1.33万
-
财政年份:2003
-
负责人:RICHARD H HAUBRICH
-
依托单位:
ACTG A5079 Physiologic Testosterone Supplements in HIV
-
批准号:7045423
-
项目类别:
-
资助金额:$1.82万
-
财政年份:2003
-
负责人:RICHARD H HAUBRICH
-
依托单位:
海外基金